<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="25055">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01905514</url>
  </required_header>
  <id_info>
    <org_study_id>PRIMA-13-002</org_study_id>
    <nct_id>NCT01905514</nct_id>
  </id_info>
  <brief_title>ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients</brief_title>
  <acronym>PRIMA</acronym>
  <official_title>ImPRoving Adherence to Immunosuppressive Therapy by Mobile Internet Application in Solid Organ Transplant Patients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <authority>South Korea: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nonadherence to immunosuppression is a leading cause of late graft rejection, chronic
      rejection and graft failure and it is regarded as a preventable cause of graft loss after
      solid organ transplantation. The purpose of this study is to evaluate whether mobile
      application for drug medication can enhance the drug adherence rate.
    </textblock>
  </brief_summary>
  <overall_status>Enrolling by invitation</overall_status>
  <start_date>September 2013</start_date>
  <completion_date type="Anticipated">June 2015</completion_date>
  <primary_completion_date type="Anticipated">December 2014</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label</study_design>
  <primary_outcome>
    <measure>adherence rate</measure>
    <time_frame>up to 6 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>biopsy proven acute rejection rate</measure>
    <time_frame>up to 6 months</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>renal function</measure>
    <time_frame>up to 6 months</time_frame>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <condition>Kidney Transplantation</condition>
  <arm_group>
    <arm_group_label>control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>using Medication event monitoring system</description>
  </arm_group>
  <arm_group>
    <arm_group_label>internet mobile application</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>using both mobile internet application and medication event monitoring system</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>internet mobile application</intervention_name>
    <arm_group_label>internet mobile application</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  1 year after kidney transplantation

          -  out-patient follow up in Seoul National University Hospital

          -  using android smartphone

          -  taking Prograf as a main immunosuppressant

          -  15-70 years

        Exclusion Criteria:

          -  patients who cannot use medication event monitoring system

          -  multiorgan transplant

          -  immunosuppression medication change within 4 weeks of randomization

          -  caregiver management of the medication regimen

          -  pregnancy

          -  patients who can not use mobile application
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>15 Years</minimum_age>
    <maximum_age>70 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jongwon Ha, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Seoul National University Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>July 2013</verification_date>
  <lastchanged_date>July 18, 2013</lastchanged_date>
  <firstreceived_date>July 18, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Hospital</investigator_affiliation>
    <investigator_full_name>Jongwon Ha</investigator_full_name>
    <investigator_title>Professor of</investigator_title>
  </responsible_party>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Immunosuppressive Agents</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
